Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis
Completed · Phase 4 · NCT05478499
Conditions: Psoriasis
At a glance
- Research payments reported, 2025
- $147,609
- U.S. investigators named
- 13
- Sites paid
- 13
- Planned or actual enrollment
- 154
About the trial
- Sponsor
- Bristol-Myers Squibb
- Tested
- Deucravacitinib (drug), Placebo (other)
- Dates
- Started 2022-10-06; completion 2024-10-17
- Results posted
- Yes
The purpose of this study is to compare the efficacy and safety of deucravacitinib to placebo in participants with moderate-to-severe scalp psoriasis.
From ClinicalTrials.gov, last updated 2025-10-28. Full record, eligibility and contacts (opens in a new tab)
Industry funding
E.r. Squibb & Sons, L.l.c. reported $147,609 in research payments for this study in 2025 (13 payments).
Products named: Sotyktu
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Dowling B. Stough IV, MD Dermatology · Hot Springs, AR
- Scott A. Fretzin, M.D. Dermatology · Indianapolis, IN
- Leon H. Kircik, MD Dermatology · Lousiville, KY
- Lawrence J. Green, MD Dermatology · Rockville, MD
- Linda F. Stein Gold, M.D. Dermatology · West Bloomfield, MI
- Steven E. Kempers, M.D. Specialist · Fridley, MN
- Jerry Bagel, MD Dermatology · East Windsor, NJ
- Jeffrey M. Weinberg, MD Dermatology · Kew Gardens, NY
- Benjamin D. Ehst, M.D., PH.D. Dermatology · Portland, OR
- Timothy Patton Specialist · Pittsburgh, PA
- Steven A. Davis, MD Dermatology · San Antonio, TX
- Stephen K. Tyring, MD PHD Dermatology · Webster, TX
- David Pariser, M.D. Dermatology · Norfolk, VA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Schweiger Dermatology and Allergy East Windsor $24,952
- Center for Clinical Studies Limited LLP $24,322
- Dawes Fretzin Clinical Research $20,109
- Minnesota Clinical Study Center $20,090
- Henry Ford Health Hospital, MI $14,736
- Burke Pharmaceutical Research $9,442
- Lawrence J Green MD Llc $9,167
- Virginia Clinical Research, Inc $5,906
- Forest Hills Dermatology Group $5,690
- Physicians Skin Care, PLLC $4,997
- The Dermatology and Laser Center of San Antonio $3,899
- Oregon Medical Research Center $2,500
- University of Pittsburgh Physicians $1,800
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.